SBIO.L vs. AGED.L
SBIO.L (Invesco Nasdaq Biotech UCITS ETF) and AGED.L (iShares Ageing Population UCITS ETF USD (Acc)) are both exchange-traded funds - SBIO.L is a Health & Biotech Equities fund tracking the NASDAQ Biotechnology TR USD, while AGED.L is a Global Equities fund tracking the Stoxx Global Ageing Population Net USD Index. Both are passively managed. Over the past 5 years, SBIO.L returned 5.79%/yr vs 6.71%/yr for AGED.L. A 0.68 correlation means they provide meaningful diversification when combined. Both charge a 0.40% expense ratio.
Performance
SBIO.L vs. AGED.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SBIO.L achieves a 14.76% return, which is significantly higher than AGED.L's 11.02% return.
SBIO.L
- 1D
- 0.44%
- 1M
- 9.18%
- 6M
- 12.82%
- YTD
- 14.76%
- 1Y
- 49.55%
- 3Y*
- 17.44%
- 5Y*
- 5.79%
- 10Y*
- 8.95%
AGED.L
- 1D
- -0.14%
- 1M
- 5.51%
- 6M
- 9.54%
- YTD
- 11.02%
- 1Y
- 25.89%
- 3Y*
- 15.70%
- 5Y*
- 6.71%
- 10Y*
- —
SBIO.L vs. AGED.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SBIO.L Invesco Nasdaq Biotech UCITS ETF | 14.76% | 32.89% | -2.00% | 6.15% | -11.85% | -0.49% | 27.35% | 25.54% | -11.34% | 21.45% |
AGED.L iShares Ageing Population UCITS ETF USD (Acc) | 11.02% | 26.75% | 7.86% | 9.03% | -14.29% | 4.61% | 13.29% | 19.47% | -13.28% | 22.24% |
Correlation
The correlation between SBIO.L and AGED.L is 0.63, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.63 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.66 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.69 |
Correlation (All Time) Calculated using the full available price history since Sep 8, 2016 | 0.68 |
The correlation between SBIO.L and AGED.L has been stable across timeframes, ranging from 0.63 to 0.69 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBIO.L vs. AGED.L — Risk / Return Rank
SBIO.L
AGED.L
SBIO.L vs. AGED.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotech UCITS ETF (SBIO.L) and iShares Ageing Population UCITS ETF USD (Acc) (AGED.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SBIO.L | AGED.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.72 | ||
| Sortino ratioReturn per unit of downside risk | +0.87 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.31 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | 6.45 | 3.12 | +3.33 |
| Martin ratioReturn relative to average drawdown | 19.17 | 11.36 | +7.81 |
Loading charts...
Drawdowns
SBIO.L vs. AGED.L - Drawdown Comparison
The maximum SBIO.L drawdown since its inception was -39.44%, roughly equal to the maximum AGED.L drawdown of -40.12%. Use the drawdown chart below to compare losses from any high point for SBIO.L and AGED.L.
Loading charts...
Drawdown Indicators
| SBIO.L | AGED.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.44% | -40.12% | +0.68% |
Max Drawdown (1Y)Largest decline over 1 year | -7.65% | -8.40% | +0.75% |
Max Drawdown (3Y)Largest decline over 3 years | -26.89% | -16.38% | -10.51% |
Max Drawdown (5Y)Largest decline over 5 years | -38.33% | -27.68% | -10.65% |
Max Drawdown (10Y)Largest decline over 10 years | -38.33% | — | — |
Current DrawdownCurrent decline from peak | -4.15% | -1.16% | -2.99% |
Average DrawdownAverage peak-to-trough decline | -16.68% | -8.54% | -8.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.58% | 2.31% | +0.27% |
Volatility
SBIO.L vs. AGED.L - Volatility Comparison
Invesco Nasdaq Biotech UCITS ETF (SBIO.L) has a higher volatility of 6.42% compared to iShares Ageing Population UCITS ETF USD (Acc) (AGED.L) at 3.77%. This indicates that SBIO.L's price experiences larger fluctuations and is considered to be riskier than AGED.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SBIO.L | AGED.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.42% | 3.77% | +2.65% |
Volatility (6M)Calculated over the trailing 6-month period | 15.51% | 12.23% | +3.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.35% | 15.33% | +5.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.26% | 17.78% | +3.48% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.15% | 17.74% | +4.41% |
SBIO.L vs. AGED.L - Expense Ratio Comparison
Both SBIO.L and AGED.L have an expense ratio of 0.40%.
Dividends
SBIO.L vs. AGED.L - Dividend Comparison
Neither SBIO.L nor AGED.L has paid dividends to shareholders.
Frequently Asked Questions
SBIO.L and AGED.L have a correlation of 0.63, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Both ETFs have the same 0.40% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.
SBIO.L and AGED.L have the same expense ratio: 0.40% per year.
SBIO.L is categorized as Health & Biotech Equities, while AGED.L is Global Equities. SBIO.L tracks NASDAQ Biotechnology TR USD, while AGED.L tracks Stoxx Global Ageing Population Net USD Index. They also come from different issuers: Invesco and iShares.
Find the right allocation for SBIO.L and AGED.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer